Increased levels of IL6 induce the expression of anti-apoptotic proteins that inhibit apoptosis and promote proliferation in cells, which in turn are associated to mediate resistance to chemotherapy in prostate, breast and lung cancer cells [48–51]. The gene discussed is IL6; the disease is lung cancer.